Illumina Launches MicroRNA Assay for Gene Expression Profiling

Illumina, Inc. has launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow reproducible miRNA expression profiling at a price less than half that of other commercially available methods, the company says.

By developing a high-density expression array with content from the miRBase Sequence Database this new tool will help researchers better understand the role microRNAs (miRNA) play in regulating messenger RNA (mRNA).

According to Robert C. Thompson, Ph.D., Assistant Professor, Molecular and Behavioral Neuroscience Institute at University of Michigan, "miRNAs are of profound interest to me given the level of regulation that brain cells have at the transcriptional and post-transcriptional levels. Illumina's new MicroRNA Assay is a solution ideally suited for high throughput analysis of brain samples, which meets my need for an application that utilizes small amounts of total RNA while generating reliable results."

With the new MicroRNA Assay for Gene Expression profiling, coupled with the recently launched Digital Gene Expression Profiling and Small RNA Analysis applications, Illumina provides the comprehensive array and sequencing-based gene expression tool kit in the industry.

Using a Digital Gene Expression approach, researchers can discover new miRNAs without prior sequence information. For high-throughput studies that validate and profile miRNA researchers can take advantage of the array-based miRNA solution.

"We are offering miRNA products at half of the cost of other commercially available methods so that researchers can conduct larger studies at a price they can afford," said Tanya Boyaniwsky, Illumina's Marketing Manager for Gene Expression. "We are committed to regularly updating these products with newly discovered miRNAs as well as information from internal small RNA discovery projects conducted on Illumina's Genome Analyzer."